口服“抗感染疫苗”预防急性呼吸道感染
[Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
作者信息
Luther P, Brachmann I, Werchan D, Wittig C, Tischner H
机构信息
Abteilung Immunologie des Forschungsinstitutes für Lungenkrankheiten und Tuberkulose, Berlin-Buch/DDR.
出版信息
Z Erkr Atmungsorgane. 1990;175(2):95-9.
PMID:2264367
Abstract
The efficacy of a newly developed polyvalent bacterial lysat vaccine "Infectvac" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.
摘要
一种新研发的多价细菌溶解产物疫苗“Infectvac”的疗效在动物实验研究中得到了测试。结果表明，局部应用（口服、气雾吸入）可使动物免受致死性细菌（肺炎链球菌）或病毒（A/PR/8/34）感染。在首次临床试验中，该药物显示出良好的耐受性。
Zotero 插件